FdaApplication

NDA 050795

Back to search

Identifiers

Properties

PropertyValue
applicant_nameMAYNE PHARMA INTERNATIONAL PTY LTD
application_typeNDA
approval_date2005-05-06

Products (8)

ProductActive ingredientStrengthDosage form
DORYXDOXYCYCLINE HYCLATEEQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET, DELAYED RELEASE;ORAL
DORYXDOXYCYCLINE HYCLATEEQ 80MG BASETABLET, DELAYED RELEASE;ORAL
DORYXDOXYCYCLINE HYCLATEEQ 200MG BASETABLET, DELAYED RELEASE;ORAL
DORYXDOXYCYCLINE HYCLATEEQ 75MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET, DELAYED RELEASE;ORAL
DORYXDOXYCYCLINE HYCLATEEQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET, DELAYED RELEASE;ORAL
DORYXDOXYCYCLINE HYCLATEEQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET, DELAYED RELEASE;ORAL
DORYX MPCDOXYCYCLINE HYCLATEEQ 120MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET, DELAYED RELEASE;ORAL
DORYX MPCDOXYCYCLINE HYCLATEEQ 60MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET, DELAYED RELEASE;ORAL

8 products